Breast cancer cells enhance tumor survival by HER2 signaling, while astrocyte-derived STAT3 and cytokines such as interleukin-6 (IL-6) and interferon-alpha (IFNα) protect tumor cells from apoptosis. This evidence concerns the gene IL6 and neoplasm.